González-Flores, Encarna http://orcid.org/0000-0002-2077-5060
Zambudio, Natalia http://orcid.org/0000-0002-8477-9431
Pardo-Moreno, Pedro http://orcid.org/0000-0003-0891-9006
Gonzalez-Astorga, Beatriz http://orcid.org/0000-0002-9160-4680
de la Rúa, Jorge Roldán http://orcid.org/0000-0003-3775-5274
Triviño-Ibáñez, Eva M. http://orcid.org/0000-0001-6604-6608
Navarro, Pablo
Espinoza-Cámac, Nataly http://orcid.org/0000-0002-8116-6963
Casado, Miguel Ángel http://orcid.org/0000-0002-8743-6653
Rodríguez-Fernández, Antonio http://orcid.org/0000-0002-6068-3160
Article History
Received: 4 May 2023
Accepted: 27 July 2023
First Online: 25 September 2023
Declarations
:
: The authors of the expert panel EGF, NZ, PPM, BGA, JRR, ETI, PN and ARF declare that they have no conflict of interest related to this project. EGF has been a speaker for TheraSphere. NEC and MAC are employees of Pharmacoeconomics and Outcomes Research Iberia (PORIB), a consultancy specializing in the economic evaluation of health interventions, which has received financial support from Boston Scientific in relation to the development of this research and writing of this document.
: The expert panel provides these recommendations to assist professionals in clinical decision-making. Since there is a continuous updating of the treatments, it cannot be assured that the information contained in this document is complete. This guide provides information that is not intended to replace the clinical judgements of health professionals due to individual variability among patients. Therefore, the use of this information is voluntary.
: Not applicable.
: Not applicable.
: Not applicable.